Neonatal proteinuria and hematuria while not common can have potentially devastating consequences if left undiagnosed and untreated. It is important to distinguish between inherited and acquired causes of proteinuria to initiate appropriate and timely treatment. With regards to hematuria, it is critical to identify true hematuria from pseudo-hematuria to balance between thorough investigation and unnecessary laboratory work up. This review provides an overview of the common causes of hematuria and proteinuria in a neonate.
INTRODUCTION
Neonatal proteinuria and hematuria, while not common, can be detrimental to the health of the neonate. Although nephrogenesis is complete in humans by 36 weeks of gestation, the glomerular filtration rate (GFR) is approximately 10-20 ml/ min/1.73 m 2 demonstrating the immaturity of the kidney [1] . Premature infants have an even lower GFR.
Neonatal proteinuria can be due to genetic causes, structural anomalies, infections, or immune mediated. The severity of proteinuria can vary based on the cause, and will determine the clinical presentation in the neonate. Normal protein excretion in a full term neonate is 68-309 mg/m 2 /24 h [2] [3] [4] .
Neonatal hematuria can be broadly classified into gross and microscopic hematuria. Microscopic hematuria is defined as more than 5 red blood cells (RBCs)/high power field and is more common in premature or low birth weight infants than healthy term neonates. In the absence of any associated renal or urological anomalies, microscopic hematuria is usually transient. Gross hematuria in a neonate requires prompt evaluation and intervention based on the cause [5 && ]. For the purpose of this review, a neonate is defined as less than 1 month of age. In this article, we will review the common causes, clinical presentation, evaluation, and management of neonatal proteinuria and hematuria.
NORMAL NEONATAL RENAL PHYSIOLOGY
The neonatal kidney takes over the placental function of regulating homeostasis at the time of birth. The GFR of a term newborn baby is only 10-20 ml/ min/1.73 m 2 and it correlates closely with the gestational age [1] . By 1-2 years of age, GFR reaches adult levels [6] . Despite tubular immaturity and low GFR in the neonatal kidney, fluid, and electrolyte homeostasis is maintained. The glomerular basement membrane, vascular endothelium of the capillaries, and podocytes are components of the glomerular filtration barrier, which prevents leakage of RBCs and protein. Disruption of the glomerular filtration barrier will result in urinary losses of RBCs and protein. In a healthy neonatal kidney, the proximal tubule function is often not mature enough to prevent leak of smaller proteins, and therefore it is normal to see increased urinary protein in a neonates' urine when compared with adult urine. The amount of physiologically normal protein excreted in the urine can be inversely correlated with gestational age [7] .
PROTEINURIA
Here, we will discuss the pathologic causes, evaluation and management of neonatal proteinuria. Of note, there are disease processes that cause both proteinuria and hematuria and they are discussed in one of the two sections. We will describe glomerular and tubular causes of proteinuria.
GLOMERULAR PROTEINURIA

Congenital nephrotic syndrome
Nephrotic syndrome is characterized by proteinuria, hypoalbuminemia, edema, and hyperlipidemia. Nephrotic syndrome presenting within 3 months of life is defined as congenital nephrotic syndrome (CNS). CNS can be broadly classified into genetic and nongenetic causes.
Genetic causes
CNS is associated with genetic mutations of proteins that are components of the glomerular filtration barrier. Nephrin and podocin are key components of the slit diaphragm that connects the foot processes of the podocytes and form a tight barrier. Homozygous mutations in these two proteins account for the majority of the genetic causes of CNS. Wilms tumor suppression gene (WT1) encodes for WT1 protein that is expressed in the podocytes, involved in kidney development, and also regulates nephrin expression. Laminin b2 encodes for LAMB2 protein, which is an integral part of the glomerular basement membrane. In a European cohort, up to 85% of the children that had CNS had mutations in podocin, nephrin, WT1, and LAMB2 proteins [8] . With the disruption of the glomerular filtration barrier, there is massive leakage of protein into the urine which results in hypoalbuminemia, and generalized edema. Renal function is normal during the first several months of life but eventually end-stage renal disease ensues. Some of the described mutations are associated with nonrenal malformations, which may provide a clue to the specific genetic mutations. These clinical manifestations include male pseudo-hermaphroditism (WT1), microcoria (LAMB2), and microcephaly with structural brain anomalies (Mowat-Galloway) [9 && ]. Commonly described genetic mutations, mutant proteins, phenotype, and extra-renal manifestations are listed in Table 1 .
Nongenetic causes
Although genetic causes of CNS are more common in the developed world, infections can also cause nephrotic syndrome [10] . These infections include congenital syphilis, rubella, cytomegalovirus, toxoplasmosis, hepatitis B, and HIV [10] . Neonatal lupus has been reported in the presence and in the absence of maternal lupus [12] [13] [14] . Nephrotic syndrome has also been described in neonates because of placental transfer of neutral endopeptidase (NEP) antibodies from feto-maternal alloimmunization [15, 16] . NEP antibodies were identified in the maternal serum and transiently in the infant's serum. Mothers were later identified as having truncating mutations in the metallomembrane endopeptidase gene encoding NEP protein. A prior exposure to the NEP protein from previous miscarriage or sperm triggered the production of NEP antibody. Membranous nephropathy is a common histopathological description in infants with infectious cause and NEP antibodies.
The evaluation of infants with CNS should include a detailed maternal history for autoimmune disease, kidney disease, medication exposure, infection screening, prenatal sonogram for amniotic fluid indices, and fetal anomalies. In the genetic forms of CNS, maternal serum and amniotic fluid alpha-feto-protein levels are elevated. A placental size of more than 25% of birth weight is seen in neonates with CNS [17] . Hypertension is noted in the presence of renal failure. As a result of the urinary losses of macromolecules and proteins, these babies are at increased risk of hypothyroidism, infections, and thrombosis. Affected babies with neonatal lupus have elevated lupus serologies, hypocomplementemia, and can present with hematuria, hypertension, and acute kidney injury (AKI) in addition to proteinuria. Babies with NEP antibodies can present with oliguria and AKI needing renal replacement therapy, but in many of these patients renal injury improves, although the risk of chronic kidney disease remains [16] .
Genetic tests are diagnostic and are commercially available for the common mutations. Renal biopsy is not diagnostic but may help guide genetic tests. Management options include albumin replacement with diuresis, adequate nutrition, use of medications such as indomethacin and angiotensin converting enzyme inhibitors to reduce GFR and thereby proteinuria. There is no role for immunosuppressive medications in the genetic forms of nephrotic syndrome. As patients develop renal failure, nephrectomy and dialysis is performed until transplant. Renal transplantation is a definitive therapy the for genetic forms of nephrotic syndrome. In the nongenetic causes, treatment of the underlying cause will help in the resolution of nephrotic syndrome.
TUBULAR PROTEINURIA
Acute kidney injury/acute tubular necrosis
The incidence of AKI in newborns is not well defined and varies from 0.4 to 3.5% of hospital admissions [18] . AKI occurs in the setting of perinatal asphyxia, hypoxia, hypotension, hypovolemia, sepsis, cardiac disease/surgery, and nephrotoxicity from medications [19, 20] . Acute tubular necrosis (ATN) is a common cause for AKI, especially in the neonatal intensive care unit and, as a consequence, proteinuria can be seen in the setting of acute tubular necrosis.
The premature infant in whom nephronogenesis is incomplete at the time of birth is particularly at risk for low nephron number, glomerular hyperfiltration, and proteinuria in childhood, which, in turn, can lead to chronic kidney disease (CKD) [21] . If there is nephron loss because of AKI, the premature infant is at an even higher risk for CKD. In these infants, persistent proteinuria can be an early marker for the development of chronic kidney disease.
The majority of protein that is filtered by the glomerulus is reabsorbed by the proximal tubule. The protein that is not reabsorbed is excreted in the urine and identified as low molecular weight protein [22] . Owing to tubular immaturity, neonates tend to have generalized aminoaciduria that is compounded in the face of prematurity [23, 24] .
Hereditary conditions associated with tubular low molecular weight proteinuria include hereditary forms of Fanconi syndrome, including cystinosis, Dent's disease, Lowes Syndrome, and mitochondropathies. As there is generalized proximal tubular dysfunction, the proteinuria in these conditions is accompanied by glucosuria, phosphaturia, hypercalciuria, and metabolic acidosis. However, neonatal presentation of these conditions is uncommon. 
HEMATURIA
In this section, we will review the common causes, evaluation, and management of neonatal hematuria. Gross hematuria in a newborn in general requires immediate evaluation but it is important to determine that it is actually hematuria. For instance, urate crystals in the diaper present as a reddish-brown or pink discoloration and is more commonly seen in states of volume depletion, especially in breast-fed neonates [25] . These urate crystals are benign and improve with increased fluid intake. Vaginal discharge because of maternal hormonal withdrawal can be mistaken for gross hematuria. Diaper rash causing skin break down or rectal bleeding can also present as blood in the diaper and be misdiagnosed as gross hematuria. In rare instances, porphyria can present with pink discoloration of the diaper. In all these conditions, urine analysis will be negative for blood. Myoglobinuria is rarely seen in neonates but has been reported in a patient with severe perinatal asphyxia [26] . Hemoglobinuria, although rare in neonates, can be seen with ABO blood group incompatibility from intravascular hemolysis [27] . In myoglobinuria and hemoglobinuria, urinalysis will be positive for blood but urine microscopy will be negative for RBCs. Common causes of neonatal hematuria are described below.
Trauma
Gross hematuria can be seen after instrumentation from urethral catheterization, suprapubic tap, or cystoscopy [28] . Hematuria is usually self-limited and intervention is seldom required. It is important to ensure that there is no obstruction to the urinary flow because of blood clots. Neonates with traumatic birth can also present with gross hematuria [29] .
Hematological disorders and vascular thrombosis
Neonates are at increased risk of thrombosis and hemorrhage because of the imbalance between anticoagulant and procoagulant factors. In addition, neonates have poor flow states, with small caliber vasculature predisposing to thrombosis. Additional neonatal risk factors include sepsis, polycythemia, umbilical catheterization, hypoxia, hypotension, and dehydration. Maternal risk factors include diabetes, antiphospholipid syndrome, thrombotic states, and chorioamnionitis. A German study concluded that neonates with renal vein thrombosis had an increased incidence of prothrombotic risk factors, including factor V mutation and elevated lipoprotein A [30] . Renal vascular thrombosis, although not common, can have detrimental consequences, including hypertension, renal atrophy, and chronic kidney disease. Renal vein thrombosis is more common than renal artery thrombosis. It is more common in males and usually occurs on the left side [31 & ]. The classic presentation of renal vein thrombosis includes gross hematuria, abdominal mass, and thrombocytopenia, although this triad is not present in all patients [32] . Renal artery thrombosis is often associated with umbilical artery catheterization and is also associated with an aortic thrombus. Patients with renal artery thrombosis present with gross hematuria, thrombocytopenia, and, in addition, have hypertension.
Ultrasound with Doppler, a commonly used imaging modality has its own limitations as the clot is often not visible, and there are nonspecific findings such as poor cortico-medullary differentiation and renal enlargement. Doppler study might demonstrate reversal of diastolic flow. Computed tomography angiogram is the gold standard but it has inherent risks of contrast nephropathy in the neonate. Dimercaptosuccinic acid scan can be used to diagnose renal atrophy with differential renal function. As umbilical catheterization is a major risk factor associated with renal vascular thrombosis, correct placement of the catheter tip, and the use of heparin infusion through the umbilical artery, can decrease the incidence of thrombosis. Treatment options include supportive therapy, removal of inciting causes, and anticoagulation [31 & ]. Hemorrhagic disease of the newborn, although rare in the developed world, can be seen in newborns that did not receive vitamin K prophylaxis and in babies who are exclusively breast fed. Babies of mothers on anticonvulsants or warfarin are also at increased risk. Gross or microscopic hematuria, although not a common site of bleeding, can be seen in newborns with hemorrhagic disease of the newborn. Vitamin K administration is the primary mode of therapy, along with supportive therapy with blood transfusions and fresh frozen plasma [33, 34] .
Infections
Urinary tract infections (UTI) can present as hematuria in a neonate, although hematuria is not a common presenting symptom. Presenting complaints include decreased feeding, vomiting, lethargy, irritability, fever, and prolonged jaundice. UTI prevalence can be as high as 20% in hospitalized premature neonates and these neonates with UTI are at risk of bacteremia and sepsis [35 & ]. Neonates with urosepsis with organisms other than Escherichia coli are at increased risk of having structural abnormalities, including vesicoureteric reflux [35 & ,36] . Hematuria with adenovirus and BK virus has been reported in immunocompetent children and should be considered in a neonate, even though there are no published reports [37, 38] .
Glomerulonephritis
Neonatal glomerulonephritis although rare has been reported. Neonatal lupus commonly presents as congenital heart block or dermopathy. In the vast majority of the patients, the mother has lupus, although neonates have been reported to present with lupus in the absence of maternal lupus. Presenting features include gross hematuria, nephrotic range proteinuria, edema, and hypertension. Laboratory work up will reveal hypocomplementemia, positive antinuclear antibody, and antidouble stranded DNA antibody. Renal biopsy findings can be variable and can demonstrate changes consistent with membranous nephropathy, membrano-proliferative glomerulonephritis, or 'full house glomerulonephritis' with glomerular immunoglobulin (IgM, IgG, IgA) and complement deposition (C1q). Treatment includes immunosuppressive therapy in consultation with the rheumatologist [39, 40] .
Neonatal hemolytic uremic syndrome (HUS) is characterized by a triad of hemolytic anemia, thrombocytopenia, and impairment of renal function. Although Shiga toxin-induced HUS is the common cause of HUS in older children, it is rare in neonates, with one case report of maternal transfer of E. coli 0157 [41] . The differential diagnosis for neonatal HUS would include HUS because of mutations in the alternate complement pathway, congenital thrombotic thrombocytopenic purpura because of mutation in the ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif) gene (Upshaw-Shulman syndrome), inborn errors of cobalamin metabolism, methylmalonic aciduriaassociated HUS, or drugs [42, 43] . Treatment options include plasma infusion/plasma exchange, and supportive therapy with blood transfusions and renal replacement therapy. Recently eculizumab, a monoclonal antibody to C5 that prevents the generation of C5b and the membrane attack complex, has been used in neonatal atypical HUS with success [42] .
Nephrocalcinosis/nephrolithiasis
Nephrocalcinosis refers to the deposition of calcium phosphate or calcium oxalate crystals within the interstitium of the kidney and has been reported to occur in 7-40% of preterm infants [44] . Nephrocalcinosis can be associated with hematuria. Risk factors for nephrocalcinosis in premature infants include the use of loop diuretics, low birth weight, relative hypercalcemia, hypocitraturia, parenteral nutrition, and metabolic acidosis [44] . Nephrocalcinosis of prematurity typically resolves with cessation of inciting factors, although it can take up to 7-8 years for complete resolution to occur. Nephrocalcinosis can also be seen in term neonates who have distal renal tubular acidosis, primary hyperparathyroidism, or Dents disease, and they are associated with hypercalciuria. Conditions of hypercalciuria can be treated with a thiazide diuretic. Although citrate therapy in older children and adults has been shown to decrease the incidence of renal stones, the use of citrate did not decrease the incidence of nephrocalcinosis in preterm neonates [45] . It is unclear if nephrocalcinosis in neonates leads to an increased risk of hypertension and chronic kidney disease, and therefore long-term follow-up is warranted [46] [47] [48] .
Structural malformations
Posterior urethral valves are usually diagnosed prenatally with bilateral hydronephrosis, however some patients present later in life with a poor urinary stream, UTI, or chronic kidney disease. Gross hematuria has been noted in a small percentage of neonates within the first month of life with posterior urethral valves [32, 49] . The precise mechanism of hematuria is unclear.
Congenital ureteropelvic junction obstruction causes hydronephrosis and can present with neonatal gross hematuria. Many theories have been proposed as to the cause of hematuria, including birth trauma, relatively large size kidneys in the neonate, poorly developed Gerota's fascia, and perinephric fat [49] . However, the incidence reported is 4/100 000 admissions, indicating that neonatal gross hematuria because of a hydronephrotic kidney is quite rare [32] .
Inherited forms of cystic kidney disease, including autosomal recessive polycystic kidney disease (ARPKD) and autosomal dominant polycystic kidney disease (ADPKD), can present in a neonate with microscopic/gross hematuria or proteinuria. The dominant form of PKD is caused by mutations in PKD1 and PKD2 genes. Although ADPKD typically presents in adulthood, it can also present in the neonatal period with enlarged hyperechoic kidneys with macrocysts [50, 51] . Having a family member with early onset ADPKD increases the risk of early presentation of the disease in the child [50] . Patients with ARPKD have enlarged and diffusely echogenic kidneys on ultrasound, decreased amniotic fluid and respiratory compromise because of pulmonary hypoplasia. Macrocysts are typically absent in the neonatal period in ARPKD [52]. Patients with ARPKD will require renal replacement therapy or transplantation when they develop end-stage renal disease [52].
Tumors
Neonatal renal tumors are rare and they constitute less than 10% of the neonatal tumors [53] . Despite advances in fetal sonography, neonatal renal tumors are commonly diagnosed during routine neonatal examinations or in the presence of other congenital anomalies. Renal tumors are also associated with syndromes such as Beckwith-Wiedemann syndrome, WAGR (Wilm's tumor, aniridia, genital anomalies, and mental retardation), and Denys-Drash (nephropathy, gonadal dysgenesis, intersex, and Wilm's tumor). It is critical to perform serial sonogram in these syndromic conditions to monitor for the development of renal tumors. Although a palpable abdominal mass is a common presenting symptom, neonates can present with hematuria. Other signs and laboratory findings include polyhydramnios, hypertension, hypercalcemia, anemia, and elevated renin levels [53, 54] . Congenital mesoblastic nephroma is the most common neonatal renal tumor and the survival rate is very good. Wilms tumor is the second most common neonatal renal tumor and most of them are low grade. For both tumors, nephro-ureterectomy is the primary treatment of choice [53] . Although bladder hemangioma is rare, it should be considered in the differential of neonatal gross hematuria [55] .
Renal cortical necrosis
Renal cortical necrosis is seen in neonates with severe hypoxic/ischemic injury leading to microvascular injury and the initiation of the coagulation cascade. Presenting signs include gross or microscopic hematuria, elevated creatinine, abnormal electrolytes, oliguria/anuria, and hypertension. Renal sonogram at the time of injury will likely be normal but follow-up sonogram will show atrophy of the kidney. The diagnostic test is the radionucleotide scan, which will show absence of perfusion of the affected kidney. Typically, there is no recovery of renal function after renal cortical necrosis [20] .
CONCLUSION
A thorough prenatal and postnatal history along with physical examination will guide the clinician toward a focused work up of neonatal proteinuria and hematuria. Urinalysis with microscopy is an essential first step of the laboratory work up.
Complete blood count will be useful to diagnose infections, bleeding disorders, and thrombocytopenia. Electrolytes, serum albumin and renal function, and urine culture should also be performed. Initial imaging should include a renal sonogram with Doppler study to evaluate renal flow and structural anomalies of the kidneys. Further work up can include coagulation studies, urine albumin/creatinine ratio, urinary calcium/creatinine ratio, computed tomography scan, voiding cystourethrogram, and urological procedures such as cystoscopy. A timely evaluation and diagnosis can prevent longterm complications.
